ClinicalTrials.gg
RecruitingNCT07043764Updated Sep 21, 2026

Caring Contacts Via Text Message for Suicidal Adolescents After Emergency Department Discharge

An interventional study of Caring Contacts Text Messages in Suicide Prevention, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Recruiting at 1 site in United States. Open to participants aged 12 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-09-21.

Sponsored by Ann & Robert H Lurie Children's Hospital of Chicago · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Sep 2026; still recruiting 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
12 Years to 17 Years
Sex
All
01

Study summary

The goal of this pilot clinical trial is to learn if Caring Contacts (brief, hopeful, supportive text messages) can be delivered to adolescents with suicidal thoughts or behaviors after discharge from the emergency department, and to understand if adolescents find it acceptable to receive Caring Contacts. Researchers will also begin to explore how suicidal thoughts and behaviors change over time among participants who receive Caring Contacts along with treatment as usual, compared to participants who only receive treatment as usual.

All participants will be invited to answer survey questions when they first enroll in the study and 1, 3, 6, and 12 months after their emergency department visit. Some participants will receive Caring Contacts (brief, hopeful, supportive text messages) after their emergency department visit. Some participants will be invited to complete an interview about their experiences receiving Caring Contacts.

02

Conditions studied

  • Suicide Prevention

Browse trials for

Keywords

  • Adolescent
  • Text Messaging
03

In context

Suicide Prevention

186 studies on the registry are indexed under Suicide Prevention; 92 are open to participants now.

This study's planned enrollment of 56 is below the median of 140 across 167 interventional studies indexed under Suicide Prevention.

Browse Suicide Prevention studies →

Lead sponsor

Ann & Robert H Lurie Children's Hospital of Chicago is the lead sponsor of 180 studies on the registry; 28 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 5 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 12 to \<18 years of age
  • Present to the emergency department with suicidal thoughts or behaviors as indicated by the Ask Suicide-Screening Questions (ASQ)
  • Have a cell phone that can receive text messages
  • Proficient in English
  • Anticipated disposition of discharge from the emergency department

Exclusion criteria

Exclusion Criteria:

  • In care of the Department of Children and Family Services
  • Unable to participate meaningfully in assent, assessments, or the intervention, as determined by the treating clinician, including any of the following: acute or chronic cognitive impairment, acute psychosis, current severe agitation, current alcohol or drug intoxication
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
56 participants (estimated)

Study arms

  • No intervention
    Treatment as Usual

    Treatment as usual consists of a suicide risk assessment during the emergency department visit, determination of disposition, safety planning, provision of crisis resources, and coordination of follow-up mental health services if indicated.

  • Experimental
    Caring Contacts

    In addition to Treatment as Usual, participants will receive Caring Contacts, consisting of brief, hopeful, supportive text messages.

    Other: Caring Contacts Text Messages

Interventions

  • OtherCaring Contacts Text Messages

    Caring Contacts are brief, hopeful, supportive text messages.

06

What researchers measure

Primary outcomes

  1. Columbia-Suicide Severity Rating Scale (C-SSRS) Self-Report Recent

    The Columbia-Suicide Severity Rating Scale (C-SSRS) Self-Report Recent measures recent suicidal ideation and behavior on a scale of 0-5, with higher scores indicating greater severity.

    Time frame: Baseline, 1 Month, 3 Months, 6 Months, 12 Months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Data will be shared through the NIMH Data Archive

Time frame: Data will be made available 1 year after completion of the study

Access criteria: Approval by NIMH Data Archive

Data sharing details ↗ · nda.nih.gov

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07043764
Responsible party
Jennifer Hoffmann (Associate Professor of Pediatrics, Ann & Robert H Lurie Children's Hospital of Chicago) — Principal investigator
First posted
Jun 29, 2025
Start date
Sep 15, 2026
Primary completion
Aug 2028 (estimated)
Completion
Aug 2028 (estimated)
Last update
Sep 21, 2026

Study contacts

Jennifer A. Hoffmann, MD, MS
Contact
jhoffmann@luriechildrens.org
312-227-4000
Jennifer A. Hoffmann, MD, MS
principal investigator · Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion